Breadcrumb Home Valeant Pharmaceuticals Legal CVS, Rite Aid join lawsuit over diabetes drug overcharging Finance Valeant CEO is the healthcare industry's highest-paid executive . . . IF he meets his numbers Government Ex-Valeant and specialty pharmacy execs charged in kickback scheme People Q&A: 'We don't set the price. Pharmaceutical manufacturers set the price.' Technology Mylan boosts EpiPen patient programs, doesn't budge on price Finance Valeant, attempting to normalize operations, names new CFO Finance Medicaid expansion cost through ACA 49% higher than previously estimated Finance Q&A: 'Drug prices are the wrong target,' says PhRMA chief Finance Valeant files overdue financial report, ending debt default Finance Valeant CEO will cite 'mistakes' in price-hiking strategy Load More Sponsored Content
